VascVersa Ltd

Back to portfolio

We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.

These cells are of the highest quality and potency, which allows them to be the starting point for a wide range of applications in regenerative medicine research and therapy.

VascVersa is based on research from The Queens University of Belfast and led by Christina O’Neill. 

Visit website
  • Life Science

    Fusion Antibodies PLC

    Fusion Antibodies is dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.

    Read more
  • Digital, Life Science

    Sonrai Analytics

    Sonrai Analytics focuses on providing a cloud–enabled bespoke knowledge platform to conduct modern–day analytics for ‘big data’

    Read more
  • Environmental, Engineering

    Oleocycle

    Olecycle’s core technology converts waste cooking oils into mixtures of low–sulphur biodiesel feed and oleochemicals, primarily purified fatty acids.

    Read more
  • Life Science

    ProAxsis

    ProAxsis specialises in the development and commercialisation of in vitro diagnostic laboratory assays and point–of–care tests designed to measure active protease biomarkers of disease.

    Read more